Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Jenny Phipps | M | - |
PharmaGap, Inc.
 PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada.
University of Ottawa
| 14 anni |
| John C. S. Lau | M | 81 |
University of Ottawa
| - |
| Michael Geist | M | - |
University of Ottawa
| - |
| Véronic Tardif | F | - |
University of Ottawa
| - |
| Lawrence Soloway | M | - |
University of Ottawa
| - |
| Michelle O'Bonsawin | F | - |
University of Ottawa
| - |
| Joanne Lefebvre | F | - |
University of Ottawa
| - |
| Alain Jolicoeur | M | - |
University of Ottawa
| - |
| Joe Geurts | M | - |
University of Ottawa
| - |
| Rakesh Jetly | M | 57 |
University of Ottawa
| - |
| Michaelle Jean | F | 66 |
University of Ottawa
| 12 anni |
| Allan Rock | M | - |
University of Ottawa
| - |
| Robert Laganiere | M | - |
University of Ottawa
| - |
| Andrew Seely | M | - |
University of Ottawa
| - |
| Donald Joseph Irvine | M | - |
University of Ottawa
| 19 anni |
| José Pereira | M | - |
University of Ottawa
| - |
| Michael Caughey | M | - |
University of Ottawa
| - |
| Michael Rudnicki | M | - |
University of Ottawa
| - |
| L. Denis Desautels | M | 80 |
University of Ottawa
| - |
| Pierre Richard | M | - |
University of Ottawa
| - |
| Jean-Paul Lacasse | M | - |
University of Ottawa
| - |
| Herbert David Graves | M | 64 |
University of Ottawa
| - |
| Robert Pitfield | M | - |
University of Ottawa
| - |
| John C. Bell | M | - |
University of Ottawa
| - |
| Vernon Harder | M | 71 |
University of Ottawa
| - |
| Pierre Louis Bourgault | M | - |
University of Ottawa
| - |
| Priya Patil | F | 61 |
University of Ottawa
| - |
| Perry Dellelce | M | - |
University of Ottawa
| - |
| Erich Mohr | M | 70 |
University of Ottawa
| - |
| Michael Grant Scott | M | - |
University of Ottawa
| - |
| John Thomas Zender | M | 84 |
University of Ottawa
| - |
| Joseph Richard Bertrand | M | - |
University of Ottawa
| - |
| Pierre Camu | M | - |
University of Ottawa
| - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Robert Letellier | M | - |
PharmaGap, Inc.
PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | - |
| Robert C. McInnis | M | - |
PharmaGap, Inc.
PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | - |
| Ian W. Malone | M | - |
PharmaGap, Inc.
PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | - |
| Kenneth K. Sokoll | M | - |
PharmaGap, Inc.
PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | - |
| Simon Goulet | M | - |
PharmaGap, Inc.
PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | - |
| Roderick M. Bryden | M | 83 |
PharmaGap, Inc.
PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | - |
| Michael Marchand | M | - |
PharmaGap, Inc.
PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | 5 anni |
| Gerald Leahy | M | - |
PharmaGap, Inc.
PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | - |
| Jennifer Arnold | M | - |
PharmaGap, Inc.
PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Canada | 42 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Michel Phipps
- Contatti personali
